Expression of immune-related signal regulatory protein on peripheral blood mononuclear cells in non-small cell lung cancer patients

Not Applicable

Completed

• Conditions: non- small cell lung cancer; blood screening; lung cancer; PBMC

• Registration Number: TCTR20190508003
• Lead Sponsor: /A

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2018-11-30
• Study Start: 2019-05-08
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Adult patients (≥18 year-old)
Newly diagnosed, treatment-naïve, pathologically confirmed advanced stage NSCLC
Sign informed consent

Exclusion Criteria

Prior systemic therapies, including cytotoxic chemotherapy, small molecule targeted therapy, immunotherapy
History of another malignancy within 5 years before enrollment
Receipt of corticosteroids or any immunosuppressive agents

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Protein expression on PBMC At enrollment Flow cytometric analysis

Secondary Outcome Measures

Name	Time	Method
/A N/A N/A